Health
CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate – Yahoo Finance
CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the expansion of its partnership with Sichuan Clover Biopharmaceuticals, Inc (China) (“Clover”) to rapidly advance the development and manufacture of Clover’s protein-based COVID-19 S-…
- CEPI to invest an additional $66m upfront in Clovers S-Trimer protein vaccine candidate.
- Funding will support clinical development in parallel with scale-up of manufacturing capacity …
Continue Reading